Patent · US Active

Cloning, expression and purification method for the preparation of ranibizumab

US9914770B2 · kind B2 · utility

4Cited by
7References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 28, 2014
Grant dateMar 13, 2018
Priority date—
Expiry dateJul 7, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

A polynucleotide sequence and a method for Ranibizumab cloning, expression and production having better yield and biologically active protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.